NeuroMetrix Inc (NURO) FinancialsNURONeuroMetrix Inc

Evaluating the bottom line, NeuroMetrix Inc maintains a gross margin of 61.56%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -335.84%, while the net margin is -305.47%. These profitability ratios, combined with a Return on Equity (ROE) of -45.38%, provide a clear picture of how effectively NURO converts its operational activities into shareholder value.

In the context of the broader market, NURO competes directly with industry leaders such as CDIO and BMRA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NURO's gross margin of 61.56% stands against CDIO's 100.00% and BMRA's -4.46%. Such benchmarking helps identify whether NeuroMetrix Inc is trading at a premium or discount relative to its financial performance.